- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-28
DOI
10.3389/fgene.2019.00621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
- (2019) Yoon Dae Han et al. Clinical Epigenetics
- ZNF582 methylation as a potential biomarker to predict cervical intraepithelial neoplasia type III/worse
- (2019) Na Li et al. MEDICINE
- Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer
- (2018) Arpit Bhargava et al. CURRENT DRUG TARGETS
- Cervical Cancer Worldwide
- (2018) Mailinh Vu et al. CURRENT PROBLEMS IN CANCER
- Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm
- (2018) Young Sook Park et al. Gut and Liver
- Precision Medicine: From Science To Value
- (2018) Geoffrey S. Ginsburg et al. HEALTH AFFAIRS
- PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
- (2018) Magdalena Absmaier et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Methylated septin 9 gene for noninvasive diagnosis and therapy monitoring of breast cancer
- (2018) Shen Chen et al. Translational Cancer Research
- The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA
- (2018) Na He et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
- (2018) IOANNIS PANAGOPOULOS et al. Cancer Genomics & Proteomics
- The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors
- (2018) Lele Song et al. Epigenomics
- Clinical performance of an analytically validated assay in comparison to microarray technology to assess PITX2 DNA-methylation in breast cancer
- (2018) Gabriele Schricker et al. Scientific Reports
- Machine learning for epigenetics and future medical applications
- (2017) Lawrence B. Holder et al. Epigenetics
- Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention
- (2017) Ana Gradíssimo et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer
- (2017) Xianneng Sheng et al. MEDICINE
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- Glioma epigenetics: From subclassification to novel treatment options
- (2017) Olga Gusyatiner et al. SEMINARS IN CANCER BIOLOGY
- Colorectal cancer screening: An updated review of the available options
- (2017) Iyad A Issa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
- (2017) Siân Pugh et al. Oncotarget
- Comparative Assessment of 4 Methods to Analyze MGMT Status in a Series of 121 Glioblastoma Patients
- (2017) Chih-Yi Hsu et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
- (2017) Jean-François Rahier et al. Clinical Epigenetics
- Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
- (2017) Tae Jeong Oh et al. Clinical Epigenetics
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
- (2016) Annemarie Boleij et al. BMC CANCER
- Screening for Colorectal Cancer
- (2016) Jennifer S. Lin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
- (2016) Sebastian Moran et al. LANCET ONCOLOGY
- The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
- (2016) Hailong Zhao et al. World Journal of Surgical Oncology
- DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
- (2016) Yutaka Hashimoto et al. Epigenomics
- Combined clinical and genetic testing algorithm for cervical cancer diagnosis
- (2016) Yu-Ligh Liou et al. Clinical Epigenetics
- Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology
- (2016) Jane Shen-Gunther et al. Clinical Epigenetics
- Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
- (2016) Susan Mitchell et al. Genes
- Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm
- (2015) Cheng-Chang Chang et al. BMC CANCER
- Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
- (2015) Mai-Britt W. Ørntoft et al. BMC CANCER
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons
- (2015) Jamie N. Bakkum-Gamez et al. GYNECOLOGIC ONCOLOGY
- Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm
- (2015) Peng Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Breast-Cancer Screening — Viewpoint of the IARC Working Group
- (2015) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Economic Analysis Of Epicup, An Epigenetic Test To Predict The Tissue Of Origin In Cancer Of Unknown Primary Site, The Usa Payors Perspective
- (2015) A Gracia et al. VALUE IN HEALTH
- Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
- (2015) Monika Bauden et al. Clinical Epigenetics
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions — A Taiwanese Gynecologic Oncology Group (TGOG) study
- (2014) Hao Lin et al. GYNECOLOGIC ONCOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
- (2014) Julien Taieb et al. LANCET ONCOLOGY
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening
- (2014) Thomas F. Imperiale et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer of Unknown Primary Site
- (2014) Gauri R. Varadhachary et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal Neoplasia
- (2013) Graham P. Lidgard et al. Clinical Gastroenterology and Hepatology
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- HPV and HPV-Associated Diseases
- (2013) Eileen F. Dunne et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer
- (2013) TaeJeong Oh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary
- (2013) George Pentheroudakis et al. Molecular Cancer
- The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?
- (2012) Eleftherios P Diamandis BMC Medicine
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g
- (2012) Véronique Quillien et al. CANCER
- Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures
- (2012) S. E. Kern CANCER RESEARCH
- Lung cancer in never smokers – A review
- (2012) Sébastien Couraud et al. EUROPEAN JOURNAL OF CANCER
- Cancer of unknown primary site
- (2012) Nicholas Pavlidis et al. LANCET
- Development and performance evaluation of a CE-IVD for measuring SHOX2 DNA methylation in bronchial aspirates for the diagnosis of lung cancer
- (2012) Dimo Dietrich et al. LUNG CANCER
- Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology
- (2011) H. Zou et al. CLINICAL CHEMISTRY
- Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates
- (2011) Dimo Dietrich INTERNATIONAL JOURNAL OF ONCOLOGY
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
- (2010) M Gerlinger et al. BRITISH JOURNAL OF CANCER
- Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse
- (2010) Hung-Cheng Lai et al. CANCER
- Identification of high-quality cancer prognostic markers and metastasis network modules
- (2010) Jie Li et al. Nature Communications
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Pulmonary preneoplasia - sequential molecular carcinogenetic events
- (2009) Sylvie Lantuéjoul et al. HISTOPATHOLOGY
- DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
- (2008) O. Hartmann et al. CLINICAL CANCER RESEARCH
- Carcinoma of unknown primary (CUP)
- (2008) Nicholas Pavlidis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science
- (2008) Nicolas Wentzensen et al. GYNECOLOGIC ONCOLOGY
- Identification of novel DNA methylation markers in cervical cancer
- (2008) Hung-Cheng Lai et al. INTERNATIONAL JOURNAL OF CANCER
- Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
- (2008) Izabela Zawlik et al. NEUROEPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started